Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON21229Completed
Open-label, single-arm trial of propranolol in migraine, sponsored by Inwendige Geneeskunde. Primary endpoints: Change in dermal blood flow response to capsaicin and Change in dermal blood flow response to saline iontophoresis. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON21229.